These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34154760)

  • 21. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
    Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
    Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Cui D; Liao Y; Li G; Chen Y
    Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
    Yilmaz MB; Yalta K; Yontar C; Karadas F; Erdem A; Turgut OO; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):431-5. PubMed ID: 17952581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M; Lehtonen L
    Curr Pharm Des; 2005; 11(4):435-55. PubMed ID: 15725064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
    Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
    Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure.
    Lelonek M; Stopczyńska I; Korościk E; Straburzyńska-Migaj E; Gruchała M
    Adv Clin Exp Med; 2020 Nov; 29(11):1305-1312. PubMed ID: 33269816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
    Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
    Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
    [No Abstract]   [Full Text] [Related]  

  • 30. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
    Heringlake M; Alvarez J; Bettex D; Bouchez S; Fruhwald S; Girardis M; Grossini E; Guarracino F; Herpain A; Toller W; Tritapepe L; Pollesello P
    Expert Rev Cardiovasc Ther; 2021 Apr; 19(4):325-335. PubMed ID: 33739204
    [No Abstract]   [Full Text] [Related]  

  • 31. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL; Fitzpatrick JT
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
    Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB
    Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
    Oliveira MT; Follador W; Martins ML; Canaviera R; Tsuji RL; Scipioni A; Barretto AC
    Arq Bras Cardiol; 2005 Jul; 85(1):9-14. PubMed ID: 16041448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure].
    Kaplangoray M; Aydın C
    Kardiologiia; 2023 Feb; 63(2):46-51. PubMed ID: 36880143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F
    Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial.
    Meng JB; Hu MH; Lai ZZ; Ji CL; Xu XJ; Zhang G; Tian S
    Med Sci Monit; 2016 May; 22():1486-96. PubMed ID: 27138236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
    Zhang YH; Qing EM; Zhang J; Huang Y; Lü R; Zhou Q; Wei BQ; An T; Qing P; Zou CH
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):555-8. PubMed ID: 22490161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of levosimendan on the cardiac function and prognosis in elderly patients with septic shock and myocardial contractility impairment].
    Xu CX; Li L; Gong SJ; Yu YH; Yan J
    Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):423-428. PubMed ID: 29925127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.